UY38385A - Concentrado y aislado de cannabinoide, método para su obtención y uso - Google Patents

Concentrado y aislado de cannabinoide, método para su obtención y uso

Info

Publication number
UY38385A
UY38385A UY0001038385A UY38385A UY38385A UY 38385 A UY38385 A UY 38385A UY 0001038385 A UY0001038385 A UY 0001038385A UY 38385 A UY38385 A UY 38385A UY 38385 A UY38385 A UY 38385A
Authority
UY
Uruguay
Prior art keywords
isolate
obtaining
cannabinoid concentrate
cannabinoid
concentrate
Prior art date
Application number
UY0001038385A
Other languages
English (en)
Inventor
Venturini del Greco Giovanni
Venturini Del Greco Lorenzo
Deborha Decorti
Original Assignee
Herbolea Biotech S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Herbolea Biotech S R L filed Critical Herbolea Biotech S R L
Publication of UY38385A publication Critical patent/UY38385A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D3/00—Distillation or related exchange processes in which liquids are contacted with gaseous media, e.g. stripping
    • B01D3/10—Vacuum distillation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Fats And Perfumes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se relaciona con un concentrado y aislado de cannabinoide, el método para su obtención y uso.
UY0001038385A 2019-08-27 2019-09-24 Concentrado y aislado de cannabinoide, método para su obtención y uso UY38385A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2019/072843 WO2021037343A1 (en) 2019-08-27 2019-08-27 Cannabinoid concentrate and isolate, method of obtaining the same and use thereof

Publications (1)

Publication Number Publication Date
UY38385A true UY38385A (es) 2021-01-29

Family

ID=67999599

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001038385A UY38385A (es) 2019-08-27 2019-09-24 Concentrado y aislado de cannabinoide, método para su obtención y uso

Country Status (15)

Country Link
US (1) US20220401405A1 (es)
EP (1) EP4022077A1 (es)
CN (1) CN114761572B (es)
AR (1) AR116672A1 (es)
AU (1) AU2019463310A1 (es)
BR (1) BR112022003557A2 (es)
CA (1) CA3149047A1 (es)
CO (1) CO2022003480A2 (es)
EC (1) ECSP22018842A (es)
IL (1) IL290751A (es)
MX (1) MX2022002475A (es)
PE (1) PE20221403A1 (es)
UY (1) UY38385A (es)
WO (1) WO2021037343A1 (es)
ZA (1) ZA202203193B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4431169A1 (en) 2023-03-17 2024-09-18 Siegfried AG Method of purifying cannabinoid components from plant extracts

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403126B1 (en) 1999-05-26 2002-06-11 Websar Innovations Inc. Cannabinoid extraction method
GB2393182B (en) 2002-09-23 2007-03-14 Gw Pharma Ltd Method of preparing cannabidiol from plant material
GB2514054A (en) * 2011-09-29 2014-11-12 Gw Pharma Ltd A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
JP2017501971A (ja) 2013-11-11 2017-01-19 ザ ワーク ショップ， エルエルシー 無溶媒加工、システムおよび方法
US9186386B2 (en) 2014-04-17 2015-11-17 Gary J. Speier Pharmaceutical composition and method of manufacturing
WO2016004410A1 (en) 2014-07-02 2016-01-07 Cannavest Corp. Novel process for generating hemp oil with a high cannabidiol (cbd) content
MX2017005277A (es) * 2014-10-21 2018-01-11 United Cannabis Corp Extractos de cannabis y métodos de preparación y uso de la misma.
UY36530A (es) * 2015-01-22 2016-08-31 Phytoplant Res S L Métodos para purificar cannabinoides, composiciones y kits de estos
ES2759568T3 (es) 2015-03-23 2020-05-11 Echo Pharmaceuticals Bv Aislado de cannabidiol de cáñamo industrial y uso del mismo en preparaciones farmacéuticas y/o cosméticas
GB2541191A (en) 2015-08-10 2017-02-15 Gw Pharma Ltd Use of cannabinoids in the treatment of epilepsy
EP3150264A1 (de) * 2015-09-30 2017-04-05 Bionorica Ethics GmbH Vakuumdestillation zur anreicherung von cbd
IL248150B (en) * 2016-09-29 2018-05-31 Garti Nissim A method for selective extraction of cannabinoid from plant origin
MX2019008373A (es) 2017-01-14 2019-12-02 Herbolea Biotech S R L Extraccion basada en lipidos asistida por enzimas y estabilizacion de fito-cannabinoides y terpenos, y productos obtenidos de los mismos.
US10828341B2 (en) * 2017-04-18 2020-11-10 Jose Rivas Method for preparation of pharmacologically-relevant compounds from botanical sources
US11759724B2 (en) * 2017-04-18 2023-09-19 Jose Rivas Method and apparatus for preparation of pharmacologically-relevant compounds from botanical sources
US10888595B2 (en) * 2017-04-18 2021-01-12 Jose Rivas Apparatus for preparation of pharmacologically-relevant compounds from botanical sources
CN107095302A (zh) * 2017-05-09 2017-08-29 何宗迅 大麻素类混合物及其在食品工业中的应用
US10189762B1 (en) * 2017-07-07 2019-01-29 Orochem Technologies, Inc. Process for purification and separation of cannabinoids, from dried hemp and cannabis leaves
GB2564459B (en) 2017-07-12 2022-03-09 Gw Res Ltd Use of cannabinoids in the treatment of a neurodegenerative disease or disorder
EP3461545A1 (de) * 2017-09-30 2019-04-03 Bionorica Ethics GmbH Kurzwegdestillation im vakuum zur anreicherung von naturstoffen

Also Published As

Publication number Publication date
ECSP22018842A (es) 2022-05-31
WO2021037343A1 (en) 2021-03-04
AR116672A1 (es) 2021-06-02
EP4022077A1 (en) 2022-07-06
CO2022003480A2 (es) 2022-05-31
BR112022003557A2 (pt) 2022-05-24
CN114761572B (zh) 2024-07-12
CA3149047A1 (en) 2021-03-04
CN114761572A (zh) 2022-07-15
ZA202203193B (en) 2023-09-27
US20220401405A1 (en) 2022-12-22
IL290751A (en) 2022-07-01
PE20221403A1 (es) 2022-09-15
AU2019463310A1 (en) 2022-04-07
MX2022002475A (es) 2022-03-22

Similar Documents

Publication Publication Date Title
CL2020000938A1 (es) Anticuerpos anti-tigit, sus composiciones y uso. (divisional solicitud 201800744)
CL2022000557A1 (es) Agonista triple de receptores de glucagón/glp-1/gip (divisional 2 solicitud 202002034)
CY1122653T1 (el) Αντισωματα αντι-τιgιτ, αντισωματα αντι-ρvrig και συνδυασμοι εξ αυτων
CL2022000448A1 (es) Autoinyector (divisional solicitud no. 201903061)
CO2021001893A2 (es) Anticuerpos anti-gdf15, composiciones y métodos de uso
CL2017000590A1 (es) Anticuerpos anti-cll-1 e inmunoconjugados
CR20180013A (es) Anticuerpos anti-tau y métodos de uso.
CL2019001254S1 (es) Herramienta de corte.
CL2019001554S1 (es) Automóvil.
CL2017003240A1 (es) Anticuerpos anti-rnf43 novedosos y métodos para su uso
BR112017009374A2 (pt) ?composições de ramnolipídeo de baixa viscosidade concentradas?
CR20160362A (es) Anticuerpos anti-jagged1 y metodos de uso
CL2021000855A1 (es) Replicones basados en alfavirus para la administración de bioterapias.
WO2018101663A3 (ko) 생체 조직 투명화용 조성물 및 이를 이용한 생체 조직 투명화 방법
CL2020001201S1 (es) Automóvil.
CO2022004797A2 (es) Anticuerpos anti-klk7, anticuerpos anti-klk5, anticuerpos multiespecíficos anti-klk5/klk7 y métodos de uso
CL2019002232S1 (es) Automóvil.
BR112018014355A2 (pt) processos para a preparação de f-benzoxazinorifamicina i e para a preparação de 2-amino-5-fluorobenzeno-1,3-diol iii
CL2021003563A1 (es) Anticuerpos para la unión a psma
CL2020000174S1 (es) Automóvil.
AR123432A1 (es) Concentrado de cannabinoides libre de thc, método de obtención del mismo y su uso
UY38385A (es) Concentrado y aislado de cannabinoide, método para su obtención y uso
CL2020000224S1 (es) Automóvil.
CL2020001248S1 (es) Cabrestante.
ES1228375Y (es) Dispositivo auxiliar para la práctica de patinaje.